Dr. Mehdi Sabzichi Radi
Founder, Chief Executive Officer and Executive Director
PhD in Pharmacy and Biomedical Sciences, with expertise in pharmaceutical development, drug delivery and formulation.
About Medarion Pharma
About Medarion Pharma
Medarion Pharma is an early-stage UK biotechnology company developing topical healthcare formulations for clearly identified needs.
Our work focuses on turning formulation concepts into well-defined product-development programmes. This includes refining formulations, assessing technical feasibility, generating appropriate evidence, planning the regulatory pathway and preparing for scalable manufacturing.
Our initial portfolio includes SkiNFiDAR® and DIAFAST®. We are developing these products for the UK market and seeking scientific, manufacturing, regulatory and commercial partners with the expertise needed to help evaluate and advance them.
Leadership Team
Leadership Team
Medarion Pharma is led by professionals with experience in pharmaceutical development, formulation, biomedical sciences and clinical biochemistry.
Dr. Hossain Bijanpour
Co-Founder and Board Member
Medical laboratory scientist and clinical biochemist with 15 years of experience in drug formulation.
Scientific Advisory Board
Scientific Advisory Board
Our scientific advisers provide expertise relevant to the evaluation and development of Medarion Pharma’s products.
Professor Ali Nokhodchi
Professor of Pharmaceutics and Drug Delivery, School of Life Sciences, University of Sussex, UK.
Dr. Amir Ata Saei
Assistant Professor, KTH Royal Institute of Technology, Stockholm; proteomics, bioinformatics, colorectal cancer and gut microbiome.
Dr. Murphy Wan
Senior Lecturer in Biomedical Sciences and Group Leader, Immunology, Microbiome & Cancer Lab, University of Portsmouth.
Dr. Roja Hadianamrei
Senior Lecturer in Pharmaceutical Science and Pharmacology Course Leader, University of Portsmouth.
Dr. Saeideh Nozohouri
Pharmaceutical scientist specialising in drug delivery, based in Boston, Massachusetts, USA.
Work with us
Help advance our products
We welcome conversations with scientific, manufacturing, regulatory and commercial partners.